nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—ganglion—germ cell cancer	0.0145	0.297	CbGeAlD
Regadenoson—Bronchospasm—Bleomycin—germ cell cancer	0.00568	0.00597	CcSEcCtD
Regadenoson—ADORA2A—telencephalon—germ cell cancer	0.00561	0.115	CbGeAlD
Regadenoson—Hypoaesthesia—Vinblastine—germ cell cancer	0.00544	0.00572	CcSEcCtD
Regadenoson—Cardiac arrest—Ifosfamide—germ cell cancer	0.00543	0.00571	CcSEcCtD
Regadenoson—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00507	0.00533	CcSEcCtD
Regadenoson—Myocardial infarction—Bleomycin—germ cell cancer	0.00505	0.0053	CcSEcCtD
Regadenoson—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00502	0.00528	CcSEcCtD
Regadenoson—Bronchospasm—Ifosfamide—germ cell cancer	0.00485	0.0051	CcSEcCtD
Regadenoson—Angina pectoris—Ifosfamide—germ cell cancer	0.00481	0.00505	CcSEcCtD
Regadenoson—ADORA2A—gonad—germ cell cancer	0.00468	0.0958	CbGeAlD
Regadenoson—Hypoaesthesia—Bleomycin—germ cell cancer	0.0046	0.00483	CcSEcCtD
Regadenoson—Ill-defined disorder—Vinblastine—germ cell cancer	0.00442	0.00465	CcSEcCtD
Regadenoson—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00434	0.00456	CcSEcCtD
Regadenoson—Renal failure—Ifosfamide—germ cell cancer	0.00432	0.00455	CcSEcCtD
Regadenoson—Myocardial infarction—Ifosfamide—germ cell cancer	0.00431	0.00453	CcSEcCtD
Regadenoson—Malaise—Vinblastine—germ cell cancer	0.00429	0.00452	CcSEcCtD
Regadenoson—Flushing—Bleomycin—germ cell cancer	0.00429	0.00451	CcSEcCtD
Regadenoson—Cardiac arrest—Etoposide—germ cell cancer	0.00429	0.00451	CcSEcCtD
Regadenoson—Convulsion—Vinblastine—germ cell cancer	0.00413	0.00434	CcSEcCtD
Regadenoson—Hypertension—Vinblastine—germ cell cancer	0.00411	0.00432	CcSEcCtD
Regadenoson—ADORA2A—adrenal gland—germ cell cancer	0.00408	0.0835	CbGeAlD
Regadenoson—Abdominal discomfort—Cisplatin—germ cell cancer	0.00408	0.00429	CcSEcCtD
Regadenoson—Erythema—Bleomycin—germ cell cancer	0.00402	0.00423	CcSEcCtD
Regadenoson—Bradycardia—Ifosfamide—germ cell cancer	0.00402	0.00423	CcSEcCtD
Regadenoson—Discomfort—Vinblastine—germ cell cancer	0.00401	0.00421	CcSEcCtD
Regadenoson—Flushing—Dactinomycin—germ cell cancer	0.004	0.00421	CcSEcCtD
Regadenoson—ADORA2A—spinal cord—germ cell cancer	0.00393	0.0804	CbGeAlD
Regadenoson—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00388	0.00408	CcSEcCtD
Regadenoson—Bronchospasm—Etoposide—germ cell cancer	0.00383	0.00403	CcSEcCtD
Regadenoson—Erythema—Dactinomycin—germ cell cancer	0.00375	0.00394	CcSEcCtD
Regadenoson—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00374	0.00393	CcSEcCtD
Regadenoson—Ill-defined disorder—Bleomycin—germ cell cancer	0.00373	0.00392	CcSEcCtD
Regadenoson—Renal failure—Cisplatin—germ cell cancer	0.00373	0.00392	CcSEcCtD
Regadenoson—Myocardial infarction—Cisplatin—germ cell cancer	0.00372	0.00391	CcSEcCtD
Regadenoson—Eye disorder—Ifosfamide—germ cell cancer	0.00369	0.00388	CcSEcCtD
Regadenoson—Tinnitus—Ifosfamide—germ cell cancer	0.00368	0.00387	CcSEcCtD
Regadenoson—Cardiac disorder—Ifosfamide—germ cell cancer	0.00366	0.00385	CcSEcCtD
Regadenoson—Flushing—Ifosfamide—germ cell cancer	0.00366	0.00385	CcSEcCtD
Regadenoson—Malaise—Bleomycin—germ cell cancer	0.00363	0.00381	CcSEcCtD
Regadenoson—Depressed level of consciousness—Methotrexate—germ cell cancer	0.00359	0.00378	CcSEcCtD
Regadenoson—Angiopathy—Ifosfamide—germ cell cancer	0.00358	0.00377	CcSEcCtD
Regadenoson—Immune system disorder—Ifosfamide—germ cell cancer	0.00357	0.00375	CcSEcCtD
Regadenoson—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00356	0.00374	CcSEcCtD
Regadenoson—ADORA2A—endocrine gland—germ cell cancer	0.00354	0.0724	CbGeAlD
Regadenoson—Cough—Bleomycin—germ cell cancer	0.00351	0.00369	CcSEcCtD
Regadenoson—ADORA2A—head—germ cell cancer	0.00349	0.0715	CbGeAlD
Regadenoson—Paraesthesia—Vinblastine—germ cell cancer	0.00349	0.00367	CcSEcCtD
Regadenoson—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00348	0.00366	CcSEcCtD
Regadenoson—Bradycardia—Cisplatin—germ cell cancer	0.00347	0.00364	CcSEcCtD
Regadenoson—Mental disorder—Ifosfamide—germ cell cancer	0.00346	0.00364	CcSEcCtD
Regadenoson—Erythema—Ifosfamide—germ cell cancer	0.00344	0.00361	CcSEcCtD
Regadenoson—Acute coronary syndrome—Etoposide—germ cell cancer	0.00342	0.0036	CcSEcCtD
Regadenoson—Chest pain—Bleomycin—germ cell cancer	0.00342	0.0036	CcSEcCtD
Regadenoson—Myalgia—Bleomycin—germ cell cancer	0.00342	0.0036	CcSEcCtD
Regadenoson—Renal failure—Etoposide—germ cell cancer	0.00342	0.00359	CcSEcCtD
Regadenoson—Myocardial infarction—Etoposide—germ cell cancer	0.00341	0.00358	CcSEcCtD
Regadenoson—Discomfort—Bleomycin—germ cell cancer	0.00338	0.00356	CcSEcCtD
Regadenoson—Malaise—Dactinomycin—germ cell cancer	0.00338	0.00356	CcSEcCtD
Regadenoson—ADORA2A—testis—germ cell cancer	0.00337	0.069	CbGeAlD
Regadenoson—Connective tissue disorder—Cisplatin—germ cell cancer	0.00335	0.00352	CcSEcCtD
Regadenoson—Pain—Vinblastine—germ cell cancer	0.00332	0.00349	CcSEcCtD
Regadenoson—Anaphylactic shock—Bleomycin—germ cell cancer	0.00328	0.00345	CcSEcCtD
Regadenoson—Vision blurred—Ifosfamide—germ cell cancer	0.00324	0.00341	CcSEcCtD
Regadenoson—Feeling abnormal—Vinblastine—germ cell cancer	0.0032	0.00337	CcSEcCtD
Regadenoson—Myalgia—Dactinomycin—germ cell cancer	0.00319	0.00336	CcSEcCtD
Regadenoson—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00319	0.00335	CcSEcCtD
Regadenoson—Eye disorder—Cisplatin—germ cell cancer	0.00318	0.00335	CcSEcCtD
Regadenoson—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00318	0.00334	CcSEcCtD
Regadenoson—Tinnitus—Cisplatin—germ cell cancer	0.00317	0.00334	CcSEcCtD
Regadenoson—Flushing—Cisplatin—germ cell cancer	0.00316	0.00332	CcSEcCtD
Regadenoson—Cardiac disorder—Cisplatin—germ cell cancer	0.00316	0.00332	CcSEcCtD
Regadenoson—Discomfort—Dactinomycin—germ cell cancer	0.00316	0.00332	CcSEcCtD
Regadenoson—Angioedema—Ifosfamide—germ cell cancer	0.00314	0.0033	CcSEcCtD
Regadenoson—ADORA2A—cerebellum—germ cell cancer	0.00312	0.0637	CbGeAlD
Regadenoson—Hypoaesthesia—Etoposide—germ cell cancer	0.0031	0.00326	CcSEcCtD
Regadenoson—Malaise—Ifosfamide—germ cell cancer	0.0031	0.00326	CcSEcCtD
Regadenoson—Immune system disorder—Cisplatin—germ cell cancer	0.00308	0.00323	CcSEcCtD
Regadenoson—Abdominal pain—Vinblastine—germ cell cancer	0.00307	0.00323	CcSEcCtD
Regadenoson—Mediastinal disorder—Cisplatin—germ cell cancer	0.00307	0.00323	CcSEcCtD
Regadenoson—Hypotension—Bleomycin—germ cell cancer	0.00307	0.00323	CcSEcCtD
Regadenoson—Palpitations—Ifosfamide—germ cell cancer	0.00304	0.00319	CcSEcCtD
Regadenoson—Cough—Ifosfamide—germ cell cancer	0.003	0.00315	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00299	0.00314	CcSEcCtD
Regadenoson—Convulsion—Ifosfamide—germ cell cancer	0.00298	0.00313	CcSEcCtD
Regadenoson—Hypertension—Ifosfamide—germ cell cancer	0.00297	0.00312	CcSEcCtD
Regadenoson—Erythema—Cisplatin—germ cell cancer	0.00296	0.00312	CcSEcCtD
Regadenoson—Paraesthesia—Bleomycin—germ cell cancer	0.00295	0.0031	CcSEcCtD
Regadenoson—Dyspnoea—Bleomycin—germ cell cancer	0.00293	0.00308	CcSEcCtD
Regadenoson—Chest pain—Ifosfamide—germ cell cancer	0.00293	0.00308	CcSEcCtD
Regadenoson—Myalgia—Ifosfamide—germ cell cancer	0.00293	0.00308	CcSEcCtD
Regadenoson—Arthralgia—Ifosfamide—germ cell cancer	0.00293	0.00308	CcSEcCtD
Regadenoson—Eye disorder—Etoposide—germ cell cancer	0.00291	0.00306	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00291	0.00306	CcSEcCtD
Regadenoson—Flushing—Etoposide—germ cell cancer	0.00289	0.00304	CcSEcCtD
Regadenoson—Cardiac disorder—Etoposide—germ cell cancer	0.00289	0.00304	CcSEcCtD
Regadenoson—Discomfort—Ifosfamide—germ cell cancer	0.00289	0.00304	CcSEcCtD
Regadenoson—Hypersensitivity—Vinblastine—germ cell cancer	0.00286	0.00301	CcSEcCtD
Regadenoson—Angiopathy—Etoposide—germ cell cancer	0.00283	0.00298	CcSEcCtD
Regadenoson—Immune system disorder—Etoposide—germ cell cancer	0.00282	0.00296	CcSEcCtD
Regadenoson—Mediastinal disorder—Etoposide—germ cell cancer	0.00281	0.00296	CcSEcCtD
Regadenoson—Pain—Bleomycin—germ cell cancer	0.00281	0.00295	CcSEcCtD
Regadenoson—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00281	0.00295	CcSEcCtD
Regadenoson—Vision blurred—Cisplatin—germ cell cancer	0.00279	0.00294	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00279	0.00293	CcSEcCtD
Regadenoson—Asthenia—Vinblastine—germ cell cancer	0.00279	0.00293	CcSEcCtD
Regadenoson—Tremor—Cisplatin—germ cell cancer	0.00278	0.00292	CcSEcCtD
Regadenoson—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00276	0.0029	CcSEcCtD
Regadenoson—Nervous system disorder—Ifosfamide—germ cell cancer	0.00275	0.00289	CcSEcCtD
Regadenoson—Ill-defined disorder—Cisplatin—germ cell cancer	0.00275	0.00289	CcSEcCtD
Regadenoson—Skin disorder—Ifosfamide—germ cell cancer	0.00273	0.00287	CcSEcCtD
Regadenoson—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00271	0.00285	CcSEcCtD
Regadenoson—Feeling abnormal—Bleomycin—germ cell cancer	0.00271	0.00284	CcSEcCtD
Regadenoson—Malaise—Cisplatin—germ cell cancer	0.00267	0.00281	CcSEcCtD
Regadenoson—Diarrhoea—Vinblastine—germ cell cancer	0.00266	0.0028	CcSEcCtD
Regadenoson—Dysgeusia—Etoposide—germ cell cancer	0.00266	0.0028	CcSEcCtD
Regadenoson—Hypotension—Ifosfamide—germ cell cancer	0.00262	0.00276	CcSEcCtD
Regadenoson—Pain—Dactinomycin—germ cell cancer	0.00262	0.00275	CcSEcCtD
Regadenoson—Urticaria—Bleomycin—germ cell cancer	0.00261	0.00274	CcSEcCtD
Regadenoson—Dizziness—Vinblastine—germ cell cancer	0.00257	0.0027	CcSEcCtD
Regadenoson—Convulsion—Cisplatin—germ cell cancer	0.00257	0.0027	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00256	0.00269	CcSEcCtD
Regadenoson—ADORA2A—brain—germ cell cancer	0.00253	0.0518	CbGeAlD
Regadenoson—Myalgia—Cisplatin—germ cell cancer	0.00252	0.00265	CcSEcCtD
Regadenoson—Feeling abnormal—Dactinomycin—germ cell cancer	0.00252	0.00265	CcSEcCtD
Regadenoson—Paraesthesia—Ifosfamide—germ cell cancer	0.00252	0.00265	CcSEcCtD
Regadenoson—Ill-defined disorder—Etoposide—germ cell cancer	0.00252	0.00265	CcSEcCtD
Regadenoson—Anxiety—Cisplatin—germ cell cancer	0.00251	0.00264	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00251	0.00263	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.0025	0.00263	CcSEcCtD
Regadenoson—Dyspnoea—Ifosfamide—germ cell cancer	0.0025	0.00263	CcSEcCtD
Regadenoson—Somnolence—Ifosfamide—germ cell cancer	0.00249	0.00262	CcSEcCtD
Regadenoson—Discomfort—Cisplatin—germ cell cancer	0.00249	0.00262	CcSEcCtD
Regadenoson—Vomiting—Vinblastine—germ cell cancer	0.00247	0.0026	CcSEcCtD
Regadenoson—Malaise—Etoposide—germ cell cancer	0.00245	0.00257	CcSEcCtD
Regadenoson—Headache—Vinblastine—germ cell cancer	0.00243	0.00256	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00242	0.00255	CcSEcCtD
Regadenoson—Abdominal pain—Dactinomycin—germ cell cancer	0.00242	0.00254	CcSEcCtD
Regadenoson—Anaphylactic shock—Cisplatin—germ cell cancer	0.00242	0.00254	CcSEcCtD
Regadenoson—Hypersensitivity—Bleomycin—germ cell cancer	0.00242	0.00254	CcSEcCtD
Regadenoson—Pain—Ifosfamide—germ cell cancer	0.0024	0.00252	CcSEcCtD
Regadenoson—Loss of consciousness—Etoposide—germ cell cancer	0.00239	0.00251	CcSEcCtD
Regadenoson—Nervous system disorder—Cisplatin—germ cell cancer	0.00237	0.00249	CcSEcCtD
Regadenoson—Cough—Etoposide—germ cell cancer	0.00237	0.00249	CcSEcCtD
Regadenoson—Tachycardia—Cisplatin—germ cell cancer	0.00236	0.00248	CcSEcCtD
Regadenoson—Asthenia—Bleomycin—germ cell cancer	0.00236	0.00248	CcSEcCtD
Regadenoson—Convulsion—Etoposide—germ cell cancer	0.00235	0.00247	CcSEcCtD
Regadenoson—Skin disorder—Cisplatin—germ cell cancer	0.00235	0.00247	CcSEcCtD
Regadenoson—Hypertension—Etoposide—germ cell cancer	0.00234	0.00246	CcSEcCtD
Regadenoson—Hyperhidrosis—Cisplatin—germ cell cancer	0.00234	0.00246	CcSEcCtD
Regadenoson—Asthma—Methotrexate—germ cell cancer	0.00233	0.00245	CcSEcCtD
Regadenoson—Feeling abnormal—Ifosfamide—germ cell cancer	0.00231	0.00243	CcSEcCtD
Regadenoson—Chest pain—Etoposide—germ cell cancer	0.00231	0.00243	CcSEcCtD
Regadenoson—Nausea—Vinblastine—germ cell cancer	0.00231	0.00243	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0023	0.00241	CcSEcCtD
Regadenoson—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00229	0.00241	CcSEcCtD
Regadenoson—Discomfort—Etoposide—germ cell cancer	0.00228	0.0024	CcSEcCtD
Regadenoson—Hypotension—Cisplatin—germ cell cancer	0.00226	0.00238	CcSEcCtD
Regadenoson—Hypersensitivity—Dactinomycin—germ cell cancer	0.00226	0.00237	CcSEcCtD
Regadenoson—Abdominal discomfort—Methotrexate—germ cell cancer	0.00224	0.00235	CcSEcCtD
Regadenoson—Urticaria—Ifosfamide—germ cell cancer	0.00223	0.00234	CcSEcCtD
Regadenoson—Abdominal pain—Ifosfamide—germ cell cancer	0.00222	0.00233	CcSEcCtD
Regadenoson—Anaphylactic shock—Etoposide—germ cell cancer	0.00222	0.00233	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.0022	0.00232	CcSEcCtD
Regadenoson—Asthenia—Dactinomycin—germ cell cancer	0.0022	0.00231	CcSEcCtD
Regadenoson—Paraesthesia—Cisplatin—germ cell cancer	0.00217	0.00228	CcSEcCtD
Regadenoson—Tachycardia—Etoposide—germ cell cancer	0.00216	0.00227	CcSEcCtD
Regadenoson—Dyspnoea—Cisplatin—germ cell cancer	0.00216	0.00227	CcSEcCtD
Regadenoson—Skin disorder—Etoposide—germ cell cancer	0.00215	0.00226	CcSEcCtD
Regadenoson—Hyperhidrosis—Etoposide—germ cell cancer	0.00214	0.00225	CcSEcCtD
Regadenoson—Diarrhoea—Dactinomycin—germ cell cancer	0.00209	0.0022	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00209	0.0022	CcSEcCtD
Regadenoson—Vomiting—Bleomycin—germ cell cancer	0.00209	0.00219	CcSEcCtD
Regadenoson—Hypotension—Etoposide—germ cell cancer	0.00207	0.00218	CcSEcCtD
Regadenoson—Rash—Bleomycin—germ cell cancer	0.00207	0.00218	CcSEcCtD
Regadenoson—Pain—Cisplatin—germ cell cancer	0.00207	0.00217	CcSEcCtD
Regadenoson—Dermatitis—Bleomycin—germ cell cancer	0.00207	0.00217	CcSEcCtD
Regadenoson—Hypersensitivity—Ifosfamide—germ cell cancer	0.00207	0.00217	CcSEcCtD
Regadenoson—Renal failure—Methotrexate—germ cell cancer	0.00205	0.00215	CcSEcCtD
Regadenoson—Asthenia—Ifosfamide—germ cell cancer	0.00201	0.00212	CcSEcCtD
Regadenoson—Feeling abnormal—Cisplatin—germ cell cancer	0.00199	0.0021	CcSEcCtD
Regadenoson—Paraesthesia—Etoposide—germ cell cancer	0.00199	0.00209	CcSEcCtD
Regadenoson—Dyspnoea—Etoposide—germ cell cancer	0.00198	0.00208	CcSEcCtD
Regadenoson—Somnolence—Etoposide—germ cell cancer	0.00197	0.00207	CcSEcCtD
Regadenoson—Nausea—Bleomycin—germ cell cancer	0.00195	0.00205	CcSEcCtD
Regadenoson—Vomiting—Dactinomycin—germ cell cancer	0.00195	0.00205	CcSEcCtD
Regadenoson—Rash—Dactinomycin—germ cell cancer	0.00193	0.00203	CcSEcCtD
Regadenoson—Diarrhoea—Ifosfamide—germ cell cancer	0.00192	0.00202	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00191	0.00201	CcSEcCtD
Regadenoson—Pain—Etoposide—germ cell cancer	0.00189	0.00199	CcSEcCtD
Regadenoson—Dizziness—Ifosfamide—germ cell cancer	0.00186	0.00195	CcSEcCtD
Regadenoson—Feeling abnormal—Etoposide—germ cell cancer	0.00183	0.00192	CcSEcCtD
Regadenoson—Nausea—Dactinomycin—germ cell cancer	0.00182	0.00191	CcSEcCtD
Regadenoson—Gastrointestinal pain—Etoposide—germ cell cancer	0.00181	0.00191	CcSEcCtD
Regadenoson—Vomiting—Ifosfamide—germ cell cancer	0.00178	0.00188	CcSEcCtD
Regadenoson—Hypersensitivity—Cisplatin—germ cell cancer	0.00178	0.00187	CcSEcCtD
Regadenoson—Rash—Ifosfamide—germ cell cancer	0.00177	0.00186	CcSEcCtD
Regadenoson—Dermatitis—Ifosfamide—germ cell cancer	0.00177	0.00186	CcSEcCtD
Regadenoson—Urticaria—Etoposide—germ cell cancer	0.00176	0.00185	CcSEcCtD
Regadenoson—Abdominal pain—Etoposide—germ cell cancer	0.00175	0.00184	CcSEcCtD
Regadenoson—Eye disorder—Methotrexate—germ cell cancer	0.00175	0.00184	CcSEcCtD
Regadenoson—Tinnitus—Methotrexate—germ cell cancer	0.00174	0.00183	CcSEcCtD
Regadenoson—Asthenia—Cisplatin—germ cell cancer	0.00174	0.00182	CcSEcCtD
Regadenoson—Cardiac disorder—Methotrexate—germ cell cancer	0.00173	0.00182	CcSEcCtD
Regadenoson—Angiopathy—Methotrexate—germ cell cancer	0.00169	0.00178	CcSEcCtD
Regadenoson—Immune system disorder—Methotrexate—germ cell cancer	0.00169	0.00177	CcSEcCtD
Regadenoson—Mediastinal disorder—Methotrexate—germ cell cancer	0.00168	0.00177	CcSEcCtD
Regadenoson—Nausea—Ifosfamide—germ cell cancer	0.00167	0.00175	CcSEcCtD
Regadenoson—Diarrhoea—Cisplatin—germ cell cancer	0.00165	0.00174	CcSEcCtD
Regadenoson—Mental disorder—Methotrexate—germ cell cancer	0.00164	0.00172	CcSEcCtD
Regadenoson—Hypersensitivity—Etoposide—germ cell cancer	0.00163	0.00172	CcSEcCtD
Regadenoson—Erythema—Methotrexate—germ cell cancer	0.00163	0.00171	CcSEcCtD
Regadenoson—Dysgeusia—Methotrexate—germ cell cancer	0.00159	0.00167	CcSEcCtD
Regadenoson—Asthenia—Etoposide—germ cell cancer	0.00159	0.00167	CcSEcCtD
Regadenoson—Vomiting—Cisplatin—germ cell cancer	0.00154	0.00162	CcSEcCtD
Regadenoson—Vision blurred—Methotrexate—germ cell cancer	0.00153	0.00161	CcSEcCtD
Regadenoson—Rash—Cisplatin—germ cell cancer	0.00153	0.0016	CcSEcCtD
Regadenoson—Dermatitis—Cisplatin—germ cell cancer	0.00152	0.0016	CcSEcCtD
Regadenoson—Diarrhoea—Etoposide—germ cell cancer	0.00152	0.00159	CcSEcCtD
Regadenoson—Ill-defined disorder—Methotrexate—germ cell cancer	0.00151	0.00159	CcSEcCtD
Regadenoson—Malaise—Methotrexate—germ cell cancer	0.00147	0.00154	CcSEcCtD
Regadenoson—Dizziness—Etoposide—germ cell cancer	0.00147	0.00154	CcSEcCtD
Regadenoson—Nausea—Cisplatin—germ cell cancer	0.00144	0.00151	CcSEcCtD
Regadenoson—Cough—Methotrexate—germ cell cancer	0.00142	0.00149	CcSEcCtD
Regadenoson—Convulsion—Methotrexate—germ cell cancer	0.00141	0.00148	CcSEcCtD
Regadenoson—Vomiting—Etoposide—germ cell cancer	0.00141	0.00148	CcSEcCtD
Regadenoson—Rash—Etoposide—germ cell cancer	0.0014	0.00147	CcSEcCtD
Regadenoson—Dermatitis—Etoposide—germ cell cancer	0.0014	0.00147	CcSEcCtD
Regadenoson—Headache—Etoposide—germ cell cancer	0.00139	0.00146	CcSEcCtD
Regadenoson—Arthralgia—Methotrexate—germ cell cancer	0.00138	0.00146	CcSEcCtD
Regadenoson—Chest pain—Methotrexate—germ cell cancer	0.00138	0.00146	CcSEcCtD
Regadenoson—Myalgia—Methotrexate—germ cell cancer	0.00138	0.00146	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00138	0.00145	CcSEcCtD
Regadenoson—Discomfort—Methotrexate—germ cell cancer	0.00137	0.00144	CcSEcCtD
Regadenoson—Anaphylactic shock—Methotrexate—germ cell cancer	0.00133	0.0014	CcSEcCtD
Regadenoson—Nausea—Etoposide—germ cell cancer	0.00132	0.00138	CcSEcCtD
Regadenoson—Nervous system disorder—Methotrexate—germ cell cancer	0.0013	0.00137	CcSEcCtD
Regadenoson—Skin disorder—Methotrexate—germ cell cancer	0.00129	0.00136	CcSEcCtD
Regadenoson—Hyperhidrosis—Methotrexate—germ cell cancer	0.00128	0.00135	CcSEcCtD
Regadenoson—Hypotension—Methotrexate—germ cell cancer	0.00124	0.0013	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00121	0.00127	CcSEcCtD
Regadenoson—Insomnia—Methotrexate—germ cell cancer	0.0012	0.00126	CcSEcCtD
Regadenoson—Paraesthesia—Methotrexate—germ cell cancer	0.00119	0.00125	CcSEcCtD
Regadenoson—Dyspnoea—Methotrexate—germ cell cancer	0.00118	0.00124	CcSEcCtD
Regadenoson—Somnolence—Methotrexate—germ cell cancer	0.00118	0.00124	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00115	0.0012	CcSEcCtD
Regadenoson—Pain—Methotrexate—germ cell cancer	0.00114	0.00119	CcSEcCtD
Regadenoson—Feeling abnormal—Methotrexate—germ cell cancer	0.00109	0.00115	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00109	0.00114	CcSEcCtD
Regadenoson—Urticaria—Methotrexate—germ cell cancer	0.00105	0.00111	CcSEcCtD
Regadenoson—Abdominal pain—Methotrexate—germ cell cancer	0.00105	0.0011	CcSEcCtD
Regadenoson—Hypersensitivity—Methotrexate—germ cell cancer	0.000978	0.00103	CcSEcCtD
Regadenoson—Asthenia—Methotrexate—germ cell cancer	0.000952	0.001	CcSEcCtD
Regadenoson—Diarrhoea—Methotrexate—germ cell cancer	0.000908	0.000955	CcSEcCtD
Regadenoson—Dizziness—Methotrexate—germ cell cancer	0.000878	0.000923	CcSEcCtD
Regadenoson—Vomiting—Methotrexate—germ cell cancer	0.000844	0.000887	CcSEcCtD
Regadenoson—Rash—Methotrexate—germ cell cancer	0.000837	0.00088	CcSEcCtD
Regadenoson—Dermatitis—Methotrexate—germ cell cancer	0.000836	0.000879	CcSEcCtD
Regadenoson—Headache—Methotrexate—germ cell cancer	0.000831	0.000874	CcSEcCtD
Regadenoson—Nausea—Methotrexate—germ cell cancer	0.000788	0.000829	CcSEcCtD
